FAQ : ITI Pharma & Healthcare Fund - Regular Plan - Growth

ITI Pharma & Healthcare Fund - Regular Plan - Growth has delivered CAGR and average rolling returns as follows :

1 Year 3 Year 5 Year 9 Year
CAGR(%) 52.55 N/A N/A N/A
Average Rolling Returns(%) 13.50 N/A N/A N/A

The Current NAV of ITI Pharma & Healthcare Fund - Regular Plan - Growth is ₹13.53.

It is better to invest in a fund with a longer track record as ITI Pharma & Healthcare Fund - Regular Plan - Growth cannot be assessed for consistency of out-performance. Funds returns are more likely to be different than its benchmark NIFTY 50 returns, as Funds portfolio is significantly different.

ITI Pharma & Healthcare Fund - Regular Plan - Growth fund’s expense ratio is 2.34%

The process for redemption is

  • Give a request for redemption of the number of units or the amount you want. The request will be acknowledged.
  • You will get information about the redemption and the NAV at which redeemed.
  • The amount will be deposited in the designated bank account.

The AUM of ITI Pharma & Healthcare Fund - Regular Plan - Growth is currently ₹157 Crores.

The Top three stocks are Sun Pharma Inds., Lupin and Dr. Reddys Lab and account for 29% of its portfolio. Top 5 and 10 stocks of fund account for 39% and 58% of fund’s portfolio respectively.

Top three sectors of ITI Pharma & Healthcare Fund - Regular Plan - Growth fund are Healthcare, Miscellaneous and Chemicals accounting for 100% of the total portfolio.

Funds Portfolio Quality is Very Good. It has a large proportion of Green Stocks.Since this is a Equity - Sectoral Fund - Pharma & Health Care it is comparatively safer to invest in this fund. However, since it has not consistently outperformed its benchmark index on an average 3-year rolling returns basis it is not the most suitable fund for SIP.

The category of ITI Pharma & Healthcare Fund - Regular Plan - Growth Fund is Equity - Sectoral Fund - Pharma & Health Care.

Rohan Korde and Dhimant Shah manage the ITI Pharma & Healthcare Fund - Regular Plan - Growth Fund.

ITI Pharma & Healthcare Fund - Regular Plan - Growth current PE ratio is 50.19 and PB ratio is 7.48

The asset allocation of ITI Pharma & Healthcare Fund - Regular Plan - Growth is Stocks : 95.35%, Debt : 4.66% and Gold : 0%

The minimum SIP amount for ITI Pharma & Healthcare Fund - Regular Plan - Growth is ₹500.00 and minimum lumpsum is ₹5000.00

The exit load for ITI Pharma & Healthcare Fund - Regular Plan - Growth is 1% on or before 12 months, Nil after 12 months

© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.